Clinical Trial Update: Treatment for Migraine and Mood (Team-M) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a treatment targeting migraine and mood disorders has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Migraine

Snippet

Sponsor: NYU Langone Health | Conditions: Migraine, Depression | Phase 2 | Status: COMPLETED | Results posted: 2023-07-18